What’s New in Anti-Diabetic and Cardiovascular Drugs
Progress in the development of medications and treatments for America’s deadliest diseases is fast-growing, but there is still much to be done.
India Firm Introduces Generic Breast Cancer Drug
Panacea Biotec, an India-based biotechnology firm, has introduced a generic breast cancer treatment medicine called PacliALL.
FDA Approves Corifact to Treat Congenital FXIII Deficiency
The U.S. Food and Drug Administration has granted marketing approval for Corifact Factor XIII Concentrate (Human) for the routine prophylactic treatment of congenital factor XIII(FXIII) deficiency.
New Drug Approved to Treat Melanoma
The U.S.Food and Drug Administration has approved a novel type of cancer vaccine called Yervoy.
Albuterol Inhalation Solution Voluntarily Recalled from Market
The Ritedose Corp. is voluntarily recalling its 0.083% Albuterol Sulfate Inhalation Solution, 3 mL in 25-, 30- and60-unit dose vials.
Specialty Drugs on the Rise
As specialty pharmaceuticals are prescribed more frequently to treat more common diseases, the number of them under development and expected to be approved by the FDA in the next several years is surpassing that of other categories of drugs.
New Melanoma Drug May Destroy Brain Tumors
Bristol-Myers Squibb’s ipilimumab has shown early promise for helping patients with advanced melanoma that has spread to the brain.
FDA Approves Prostate Cancer Drug
A first-of-its-kind prostate cancer treatment that uses the body’s immune system to fight the disease has been approved by the U.S. Food and Drug Administration.
Octagam Withdrawal Issued for All Lots
Octapharma USA has initiated a voluntary withdrawal of all lots of Octagam (immune globulin intravenous [human] 5% liquid preparation) from the U.S. marketplace.